Analysen von Andrew C. Weiss

01.12.10 Novartis buy Vontobel Research
30.11.10 Basilea Pharmaceutica hold Vontobel Research
29.11.10 Basilea Pharmaceutica hold Vontobel Research
26.11.10 Basilea Pharmaceutica hold Vontobel Research
18.11.10 Novartis buy Vontobel Research
11.11.10 Novartis buy Vontobel Research
08.11.10 Newron PharmaceuticalsAz. buy Vontobel Research
04.11.10 Newron PharmaceuticalsAz. buy Vontobel Research
03.11.10 Novartis buy Vontobel Research
02.11.10 Basilea Pharmaceutica hold Vontobel Research
29.10.10 Novartis buy Vontobel Research
25.10.10 Novartis buy Vontobel Research
22.10.10 Actelion hold Vontobel Research
22.10.10 Novartis buy Vontobel Research
21.10.10 Actelion hold Vontobel Research
21.10.10 Novartis buy Vontobel Research
13.10.10 Novartis buy Vontobel Research
12.10.10 Novartis buy Vontobel Research
07.10.10 Novartis buy Vontobel Research
06.10.10 Actelion hold Vontobel Research
05.10.10 Novartis buy Vontobel Research
01.10.10 Novartis buy Vontobel Research
30.09.10 Novartis buy Vontobel Research
27.09.10 Actelion hold Vontobel Research
24.09.10 Novartis buy Vontobel Research
22.09.10 Novartis buy Vontobel Research
20.09.10 Novartis hold Vontobel Research
15.09.10 Addex Therapeutics hold Vontobel Research
14.09.10 Santhera Pharmaceuticals hold Vontobel Research
13.09.10 Novartis hold Vontobel Research
10.09.10 Newron PharmaceuticalsAz. buy Vontobel Research
10.09.10 Basilea Pharmaceutica hold Vontobel Research
10.09.10 Novartis hold Vontobel Research
27.08.10 Novartis hold Vontobel Research
26.08.10 Novartis hold Vontobel Research
24.08.10 Basilea Pharmaceutica hold Vontobel Research
19.08.10 Basilea Pharmaceutica hold Vontobel Research
26.07.10 Novartis hold Vontobel Research
21.07.10 Actelion hold Vontobel Research
20.07.10 Actelion hold Vontobel Research
12.07.10 Novartis halten Vontobel Research
07.07.10 Novartis halten Vontobel Research
01.07.10 Novartis halten Vontobel Research
01.07.10 Acino halten Vontobel Research
30.06.10 Acino halten Vontobel Research
28.06.10 Basilea Pharmaceutica halten Vontobel Research
28.06.10 Novartis halten Vontobel Research